- 1. ADD
- (UMLS (HL7) C1548443) =Intellectual Product =Problem/goal action code;
| - 19. additional locator
- [This can be a unit designator, such as apartment number, suite number, or floor. There may be several unit designators in an address (e.g., "3rd floor, Appt. 342"). This can also be a designator pointing away from the location, rather than specifying a smaller location within some larger one (e.g., Dutch "t.o." means "opposite to" for house boats located across the street facing houses). ( HL7V3.0 )] (UMLS (HL7) C1550716) =Idea or Concept =AddressPartType;
=unit designator;
unit identifier;
|
- 2. Add ordered tests to the existing specimen
- (UMLS (HL7) C1546519) =Intellectual Product =Specimen Action Code;
| - 20. Additional payment for service not provided by Medicare
- (UMLS (HL7) C1547455) =Intellectual Product =OCE Edit Code;
|
- 3. Add personnel record
- (UMLS (HL7) C1548071) =Idea or Concept =Message type;
| - 21. Additional tissue required
- (UMLS (HL7) C1547221) =Intellectual Product =Tissue Type Code;
|
- 4. Add record to master file
- (UMLS (HL7) C1549606) =Intellectual Product =Record-level event code;
| - 22. Additional X Chromosome
- (UMLS (NCI) C1510777) =Cell or Molecular Dysfunction
|
- 5. ADD-Type Zinc-Finger
- (UMLS (NCI) C1510685) =Amino Acid Sequence ;
| - 23. Additive
- (UMLS (HL7) C1549547) =Idea or Concept =RX Component Type;
|
- 6. Add/change billing account
- (UMLS (HL7) C1548013) =Idea or Concept =Message type;
| - 24. additive
- [A substance that is added to a system or compound to improve its characteristics. ( NCI )] (UMLS (HL7) C1550602) =Substance =ingredient;
|
- 7. Add/Insert
- (UMLS (HL7) C1548565) =Intellectual Product =Action Code;
◊ (UMLS (HL7) C1549771) Intellectual Product Segment action code; | - 25. additive, non-propagating
- [The association adds to the existing context associated with the Act, but will not propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Non-Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts for the purpose of this Act. However only the previously propagated authors will propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552005) =Idea or Concept =ContextControlAdditive;
ContextControlNonPropagating |
- 8. Added Concurrent Therapy
- [Instituted an additional therapy to mitigate potential negative effects ( HL7V3.0 )] (UMLS (HL7) C1555298) =Intellectual Product =Other Action Taken;
| - 26. additive, propagating
- [The association adds to the existing context associated with the Act, and will propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts, and will itself propagate with the other authors to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552003) =Idea or Concept =ContextControlAdditive;
ContextControlPropagating |
- 9. Addendum
- [An appendage to an existing document that contains supplemental information. The parent document remains content is unaltered. ( NCI )] (UMLS (NCI) C1510776) =Intellectual Product
| - 27. Additive/Preservative
- (UMLS (HL7) C1547765) =Biomedical or Dental Material =HL7 Vocabulary Version 2.5;
=ACETIC ACID;
Polydesis;
Potassium/K EDTA;
Potassium Oxalate;
FLUORIDE (AS SODIUM FLUORIDE);
HEPARIN SODIUM;
fibrinogenase;
Thymol;
toluene;
Bouin's solution;
nitric acid;
Phenol;
ACD Solution A;
Sodium Fluoride 10 MG;
ACD Solution B;
Amies transport medium;
Bacterial Transport medium;
Buffered 10% formalin;
Borate Boric Acid;
Buffered skim milk;
3.2% Citrate;
3.8% Citrate;
Carson's Modified 10% formalin;
Cary Blair Medium;
Chlamydia transport medium;
CTAD (this should be spelled out if not universally understood);
Potassium/K EDTA 15%;
Potassium/K EDTA 7.5%;
Sodium/Na EDTA;
Enteric bacteria transport medium;
Enteric plus;
10% Formalin;
"Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)"
;Sodium Fluoride, 100mg;
6N HCL;
Ammonium heparin;
Lithium/Li Heparin;
Jones Kendrick Medium;
Karnovsky's fixative;
Lithium iodoacetate;
M4;
M4-RT;
M5;
Michel's transport medium;
MMD transport medium;
Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride;
Pages's Saline;
Reagan Lowe Medium;
Siliceous earth, 12 mg;
SPS(this should be spelled out if not universally understood);
Serum Separator Tube (Polymer Gel);
Stuart transport medium;
Thyoglycollate broth;
Ureaplasma transport medium;
Viral Transport medium;
Buffered Citrate (Westergren Sedimentation Rate);
None |
- 10. Adderall
- (UMLS (NCI) C0290795) =Organic Chemical; Pharmacologic Substance ;
| - 28. Address
- (UMLS (HL7) C1547327) =Intellectual Product =Value type;
|
- 11. Adderall XR
- (UMLS (NCI) C1170024) Adderall-XR =Organic Chemical; Pharmacologic Substance ;
| - 29. Address
- (UMLS (HL7) C1578437) =Intellectual Product =Data type;
|
- 12. ADDH
- [A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV) ( MSH )] (UMLS (CSP) C1263846) ADHD;
ADHD (attention deficit hyperactivity disorder);
Attention deficit disorder of childhood with hyperactivity;
Attention Deficit Disorder with Hyperactivity;
attention deficit hyperactivity disorder;
ATTN DEFICIT W HYPERACT;
HYPERKINETIC SYND NOS;
Hyperkinetic syndrome of childhood;
Unspecified hyperkinetic syndrome of childhood =Mental or Behavioral Dysfunction =Attention Deficit and Disruptive Behavior Disorders;
| - 30. Address
- [For attributes representing the location at which an organization, person, or item may be found or reached. ( HL7V3.0 )] (UMLS (HL7) C1578436) =Intellectual Product =MDFAttributeType;
|
- 13. addiction
- [Uncontrollable craving, seeking, and use of a substance such as a drug or alcohol. ( NCI )] (UMLS (NCI) C0085281) =Mental or Behavioral Dysfunction
| - 31. Address Part
- (UMLS (HL7) C1552678) =Idea or Concept =Character;
|
- 14. Addiction (Substance Use Disorder)
- (UMLS (HL7) C1555895) =Intellectual Product =Counselor;
◊ (UMLS (HL7) C1555901) Intellectual Product Psychologist; ◊ (UMLS (HL7) C1555965) Intellectual Product Registered Nurse; | - 32. Address type
- (UMLS (HL7) C1547607) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Firm/Business;
Bad address;
Birth delivery location (address where birth occurred);
Residence at birth (home address at time of birth);
Current Or Temporary;
Country Of Origin;
Home;
Legal Address;
Mailing;
Birth (nee) (birth address, not otherwise specified);
Office;
Permanent;
Registry home. Refers to the information system, typically managed by a public health agency, that stores patient information such as immunization histories or cancer data, regardless of where the patient obtains services. |
- 15. Addiction Medicine
- (UMLS (HL7) C1555726) =Intellectual Product =Anesthesiology;
◊ (UMLS (HL7) C1555744) Intellectual Product Family Practice; ◊ (UMLS (HL7) C1555751) Intellectual Product Internal Medicine; ◊ (UMLS (HL7) C1555861) Intellectual Product Psychiatry & Neurology; | - 33. AddressPartType
- [Discussion: The hierarchical nature of these concepts shows composition. E.g. "Street Name" is part of "Street Address Line" ( HL7V3.0 )] (UMLS (HL7) C1553795) =Intellectual Product =CodeSystem;
=postal code;
country;
state or province;
municipality;
additional locator;
county or parish;
street address line;
care of;
precinct;
building number suffix;
delivery address line;
census tract;
delimiter;
|
- 16. Addiction Psychiatry
- (UMLS (HL7) C1555862) =Intellectual Product =Psychiatry & Neurology;
| - 34. AddressUse
- (UMLS (HL7) C1698330) =Spatial Concept ;
=PostalAddressUse;
=job site;
home address;
temporary address;
birthplace |
- 17. Addison's disease
- [disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol. ( CSP )] (UMLS (CSP) C0001403) =Disease or Syndrome
| - 35. adduct
- [compound produced by the mixing of two or more chemicals or a complex that forms when a chemical binds to a biological molecule, such as DNA or a protein. ( CSP )] (UMLS (CSP) C0596040) =Chemical Viewed Structurally ;
=chemical bond;
|
- 18. Additional information
- (UMLS (HL7) C1546922) =Temporal Concept =Report timing;
| - 36. ADDUCTOR TENOTOMY OF HIP
- [ ] (UMLS (ICD9CM) C0407093) =Therapeutic or Preventive Procedure
|
home
